Word

CRISPR THERAPEUTICS

Status

Pending

Status Code

638

Status Date

Wednesday, May 1, 2024

Serial Number

98164705

Mark Type

3

Filing Date

Tuesday, September 5, 2023

Trademark Owner History

CRISPR Therapeutics AG

Classifications

41 Education services, namely, providing online non-downloadable articles and newsletters in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy

5 Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders

42 Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

The mark consists of an incomplete square with a break in the lower right of the square. At the bottom of the square below the break appears a shaded rectangle. In the lower middle of the square appears the stylized word "CRISPR", with the second "R" connected to the square. In the shaded rectangle appears the stylized word "THERAPEUTICS".
Color is not claimed as a feature of the mark.

Trademark Events

Sep 8, 2023

New Application Entered

Sep 28, 2023

New Application Office Supplied Data Entered

Sep 29, 2023

Notice Of Design Search Code E-Mailed

May 1, 2024

Assigned To Examiner